一品红磷酸奥司他韦胶囊补充申请获批

Core Viewpoint - The announcement by Yipinhong indicates the approval of a new specification for Oseltamivir Phosphate Capsules, which is expected to enhance the company's product line and positively impact sales [1] Group 1: Company Developments - Yipinhong's wholly-owned subsidiary, Guangzhou Yipinhong Pharmaceutical Co., Ltd., received approval from the National Medical Products Administration for a supplemental application regarding Oseltamivir Phosphate Capsules [1] - The approval includes the addition of a 30mg specification, along with changes to quality standards and production processes [1] - This approval signifies that the company is now qualified to sell this specification of the drug in the domestic market, thereby enriching its product pipeline and categories [1]